Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic & Translational -> Basic Science (O)

Validation, Detection & Molecular Imaging of Death Receptor 5 in Gastrointestinal Cancer Patients

Shujing Wang, Jin Ding, Hua Zhu and Zhi Yang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 345;
Shujing Wang
1Peking University Cancer Hospital Beijing China
3Peking University Cancer Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin Ding
2Beijing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hua Zhu
1Peking University Cancer Hospital Beijing China
3Peking University Cancer Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi Yang
4Peking University Cancer Hospital & Institute Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 61 no. supplement 1 345

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2020.

Copyright & Usage 
© 2020

Author Information

  1. Shujing Wang1,3,
  2. Jin Ding2,
  3. Hua Zhu1,3 and
  4. Zhi Yang4
  1. 1Peking University Cancer Hospital Beijing China
  2. 2Beijing
  3. 3Peking University Cancer Hospital Beijing China
  4. 4Peking University Cancer Hospital & Institute Beijing China

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2020 to April 2025

AbstractFullPdf
May 20201100
Jun 20202900
Jul 20201200
Aug 20201500
Sep 2020700
Oct 20201600
Nov 20201100
Dec 2020900
Jan 20211500
Feb 20211500
Mar 20211300
Apr 20212000
May 20211200
Jun 20211100
Jul 2021800
Aug 20211300
Sep 2021700
Oct 20211500
Nov 2021900
Dec 2021700
Jan 2022500
Feb 20221200
Mar 2022400
Apr 20221200
May 20221400
Jun 20221000
Jul 2022700
Aug 2022800
Sep 20221200
Oct 2022200
Nov 2022600
Dec 2022100
Jan 2023400
Feb 2023600
Mar 2023400
Apr 2023400
May 2023300
Jun 2023400
Jul 2023700
Aug 2023700
Sep 20231100
Oct 2023900
Nov 2023200
Dec 2023100
Jan 2024600
Feb 2024600
Mar 2024200
Apr 2024500
May 2024600
Jun 2024700
Jul 20241500
Aug 2024700
Sep 20241100
Oct 2024600
Nov 2024600
Dec 2024600
Feb 2025900
Mar 2025400
Apr 2025200
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Validation, Detection & Molecular Imaging of Death Receptor 5 in Gastrointestinal Cancer Patients
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Validation, Detection & Molecular Imaging of Death Receptor 5 in Gastrointestinal Cancer Patients
Shujing Wang, Jin Ding, Hua Zhu, Zhi Yang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 345;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Validation, Detection & Molecular Imaging of Death Receptor 5 in Gastrointestinal Cancer Patients
Shujing Wang, Jin Ding, Hua Zhu, Zhi Yang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 345;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic & Translational -> Basic Science (O)

  • New Artificial intelligence model for 18F-Choline PET/CT in evaluation of high-risk prostate cancer outcome: texture analysis and radiomics features classification for prediction of disease progression
  • Assessment of variability of18F-DCFPyL PSMA PET/CT and PET/MR quantitative parameters from reference standard organs
  • Differences and similarities in biodistribution, pharmacokinetics and metabolites of 211At-MABG versus 123I-MIBG in normal mice
Show more Oncology: Basic & Translational -> Basic Science (O)

Basic Oncology & Translational III

  • The First in Human Study of 124I-JS001 PET/CT & PET/MR Detecting PD-1 Expression In Patients with Melanoma
  • First-in-Human Study of a64Cu-Labeled Long-acting Integrin αvβ3 Targeting Molecule64Cu-NOTA-EB-RGD in Healthy Volunteers and GBM Patients
  • Preliminary diagnostic performance of [68Ga ]-NeoBOMB1 in patients with gastrin-releasing peptide receptor-positive breast, prostate, colorectal or lung tumors (NeoFIND)
Show more Basic Oncology & Translational III

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire